ID

36060

Descrizione

An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02262728

collegamento

https://clinicaltrials.gov/show/NCT02262728

Keywords

versioni (2)
  1. 12/04/19 12/04/19 -
  2. 20/09/21 20/09/21 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

12 aprile 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Hepatitis C, Chronic NCT02262728

Inglese

Eligibility Hepatitis C, Chronic NCT02262728

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
documented chronic hepatitis c virus (hcv) infection: diagnosis of hcv more than (>) 6 months before the screening visit, either by detectable hcv ribonucleic acid (rna), a hcv positive antibody or the presence of histological changes consistent with chronic hepatitis
Descrizione

Chronic Hepatitis C Disease length | Hepatitis C virus RNA Detectable | Hepatitis C antibody positive | Change Histological Consistent with Chronic Hepatitis

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0524910
UMLS CUI [1,2]
C0872146
UMLS CUI [2,1]
C0369335
UMLS CUI [2,2]
C3830527
UMLS CUI [3]
C0281863
UMLS CUI [4,1]
C0392747
UMLS CUI [4,2]
C0205462
UMLS CUI [4,3]
C0332290
UMLS CUI [4,4]
C0019189
hcv genotype 1 or 4 infection and hcv rna plasma level >10,000 international unit per milliliter (iu/ml)
Descrizione

Hepatitis C Genotype determination | Hepatitis C virus RNA assay

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0019196
UMLS CUI [1,2]
C1533728
UMLS CUI [2]
C1272251
presence of cirrhosis, which is defined as a fibroscan with a result of >14.5 kilopascals (kpa) at screening
Descrizione

Liver Cirrhosis | Fibroscan

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023890
UMLS CUI [2]
C4522043
hcv treatment-naive participants: participant has not received treatment with any approved or investigational drug for the treatment of hcv infection and hcv treatment-experienced participants: participant has had at least 1 documented previous course of a non-direct-acting antiviral agent (daa), interferon (ifn)-based hcv therapy (with or without ribavirin [rbv]). last dose in this previous course should have occurred at least 2 months prior to screening
Descrizione

Therapy naive | Hepatitis C Untreated | Therapeutic procedure Experience Hepatitis C | DIRECT ACTING ANTIVIRALS Absent | Interferon | Ribavirin | Ribavirin Absent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0919936
UMLS CUI [2,1]
C0019196
UMLS CUI [2,2]
C0332155
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C0596545
UMLS CUI [3,3]
C0019196
UMLS CUI [4,1]
C3653501
UMLS CUI [4,2]
C0332197
UMLS CUI [5]
C3652465
UMLS CUI [6]
C0035525
UMLS CUI [7,1]
C0035525
UMLS CUI [7,2]
C0332197
decompensated liver disease: panel 1: child pugh a (mild hepatic impairment) with evidence of portal hypertension [confirmed by the presence of esophageal varices on gastroscopy or hepatic venous pressure gradient (hvpg) greater than or equal to (>=) 10 millimeter of mercury (mm hg)], panel 2: child-pugh b (moderate hepatic impairment)
Descrizione

Decompensated liver disease | Child-Pugh Classification | Hepatic impairment Mild | Hypertension, Portal | Esophageal Varices Endoscopy of stomach | Hepatic venous pressure gradient | Child-Pugh Classification | Hepatic impairment Moderate

Tipo di dati

boolean

Alias
UMLS CUI [1]
C4075847
UMLS CUI [2]
C2347612
UMLS CUI [3,1]
C0948807
UMLS CUI [3,2]
C2945599
UMLS CUI [4]
C0020541
UMLS CUI [5,1]
C0014867
UMLS CUI [5,2]
C0017195
UMLS CUI [6]
C4049263
UMLS CUI [7]
C2347612
UMLS CUI [8,1]
C0948807
UMLS CUI [8,2]
C0205081
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
co-infection with any hcv genotype
Descrizione

HCV coinfection Genotype

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1698259
UMLS CUI [1,2]
C1533728
co-infection with human immunodeficiency virus (hiv)-1 or -2 (positive hiv-1 or hiv-2 antibodies test at screening)
Descrizione

Coinfection HIV-1 | Coinfection HIV-2 | Serum HIV-1 antibody test Positive | Serum antibody hiv-2 Positive

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0275524
UMLS CUI [1,2]
C0019704
UMLS CUI [2,1]
C0275524
UMLS CUI [2,2]
C0019707
UMLS CUI [3,1]
C2208696
UMLS CUI [3,2]
C1514241
UMLS CUI [4,1]
C3469372
UMLS CUI [4,2]
C1514241
co-infection with hepatitis b virus (hepatitis b surface antigen [hbsag] positive)
Descrizione

HBV coinfection | Hepatitis B surface antigen positive

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2242656
UMLS CUI [2]
C0149709
any evidence of liver disease of non-hcv etiology. this includes, but is not limited to, acute hepatitis a infection, drug- or alcohol-related liver disease, autoimmune hepatitis, hemochromatosis, wilson's disease, alpha-1 antitrypsin deficiency, non-alcoholic steatohepatitis, primary biliary cirrhosis, or any other non-hcv liver disease considered clinically significant by the investigator
Descrizione

Liver diseases | Etiology Absent Hepatitis C virus | Hepatitis A | Drug-Induced Liver Disease | Alcoholic Liver Diseases | Hepatitis, Autoimmune | Hemochromatosis | Hepatolenticular Degeneration | alpha 1-Antitrypsin Deficiency | Nonalcoholic Steatohepatitis | Primary biliary cirrhosis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2,1]
C0015127
UMLS CUI [2,2]
C0332197
UMLS CUI [2,3]
C0220847
UMLS CUI [3]
C0019159
UMLS CUI [4]
C0860207
UMLS CUI [5]
C0023896
UMLS CUI [6]
C0241910
UMLS CUI [7]
C0018995
UMLS CUI [8]
C0019202
UMLS CUI [9]
C0221757
UMLS CUI [10]
C3241937
UMLS CUI [11]
C0008312
use of any disallowed therapies before the planned first dose of study drugs
Descrizione

Therapy Illicit

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0332266
Ritorna all'inizio della pagina

Similar models

Eligibility Hepatitis C, Chronic NCT02262728

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Chronic Hepatitis C Disease length | Hepatitis C virus RNA Detectable | Hepatitis C antibody positive | Change Histological Consistent with Chronic Hepatitis
Item
documented chronic hepatitis c virus (hcv) infection: diagnosis of hcv more than (>) 6 months before the screening visit, either by detectable hcv ribonucleic acid (rna), a hcv positive antibody or the presence of histological changes consistent with chronic hepatitis
boolean
C0524910 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0369335 (UMLS CUI [2,1])
C3830527 (UMLS CUI [2,2])
C0281863 (UMLS CUI [3])
C0392747 (UMLS CUI [4,1])
C0205462 (UMLS CUI [4,2])
C0332290 (UMLS CUI [4,3])
C0019189 (UMLS CUI [4,4])
Hepatitis C Genotype determination | Hepatitis C virus RNA assay
Item
hcv genotype 1 or 4 infection and hcv rna plasma level >10,000 international unit per milliliter (iu/ml)
boolean
C0019196 (UMLS CUI [1,1])
C1533728 (UMLS CUI [1,2])
C1272251 (UMLS CUI [2])
Liver Cirrhosis | Fibroscan
Item
presence of cirrhosis, which is defined as a fibroscan with a result of >14.5 kilopascals (kpa) at screening
boolean
C0023890 (UMLS CUI [1])
C4522043 (UMLS CUI [2])
Therapy naive | Hepatitis C Untreated | Therapeutic procedure Experience Hepatitis C | DIRECT ACTING ANTIVIRALS Absent | Interferon | Ribavirin | Ribavirin Absent
Item
hcv treatment-naive participants: participant has not received treatment with any approved or investigational drug for the treatment of hcv infection and hcv treatment-experienced participants: participant has had at least 1 documented previous course of a non-direct-acting antiviral agent (daa), interferon (ifn)-based hcv therapy (with or without ribavirin [rbv]). last dose in this previous course should have occurred at least 2 months prior to screening
boolean
C0919936 (UMLS CUI [1])
C0019196 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
C0087111 (UMLS CUI [3,1])
C0596545 (UMLS CUI [3,2])
C0019196 (UMLS CUI [3,3])
C3653501 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C3652465 (UMLS CUI [5])
C0035525 (UMLS CUI [6])
C0035525 (UMLS CUI [7,1])
C0332197 (UMLS CUI [7,2])
Decompensated liver disease | Child-Pugh Classification | Hepatic impairment Mild | Hypertension, Portal | Esophageal Varices Endoscopy of stomach | Hepatic venous pressure gradient | Child-Pugh Classification | Hepatic impairment Moderate
Item
decompensated liver disease: panel 1: child pugh a (mild hepatic impairment) with evidence of portal hypertension [confirmed by the presence of esophageal varices on gastroscopy or hepatic venous pressure gradient (hvpg) greater than or equal to (>=) 10 millimeter of mercury (mm hg)], panel 2: child-pugh b (moderate hepatic impairment)
boolean
C4075847 (UMLS CUI [1])
C2347612 (UMLS CUI [2])
C0948807 (UMLS CUI [3,1])
C2945599 (UMLS CUI [3,2])
C0020541 (UMLS CUI [4])
C0014867 (UMLS CUI [5,1])
C0017195 (UMLS CUI [5,2])
C4049263 (UMLS CUI [6])
C2347612 (UMLS CUI [7])
C0948807 (UMLS CUI [8,1])
C0205081 (UMLS CUI [8,2])
Item Group
C0680251 (UMLS CUI)
HCV coinfection Genotype
Item
co-infection with any hcv genotype
boolean
C1698259 (UMLS CUI [1,1])
C1533728 (UMLS CUI [1,2])
Coinfection HIV-1 | Coinfection HIV-2 | Serum HIV-1 antibody test Positive | Serum antibody hiv-2 Positive
Item
co-infection with human immunodeficiency virus (hiv)-1 or -2 (positive hiv-1 or hiv-2 antibodies test at screening)
boolean
C0275524 (UMLS CUI [1,1])
C0019704 (UMLS CUI [1,2])
C0275524 (UMLS CUI [2,1])
C0019707 (UMLS CUI [2,2])
C2208696 (UMLS CUI [3,1])
C1514241 (UMLS CUI [3,2])
C3469372 (UMLS CUI [4,1])
C1514241 (UMLS CUI [4,2])
HBV coinfection | Hepatitis B surface antigen positive
Item
co-infection with hepatitis b virus (hepatitis b surface antigen [hbsag] positive)
boolean
C2242656 (UMLS CUI [1])
C0149709 (UMLS CUI [2])
Liver diseases | Etiology Absent Hepatitis C virus | Hepatitis A | Drug-Induced Liver Disease | Alcoholic Liver Diseases | Hepatitis, Autoimmune | Hemochromatosis | Hepatolenticular Degeneration | alpha 1-Antitrypsin Deficiency | Nonalcoholic Steatohepatitis | Primary biliary cirrhosis
Item
any evidence of liver disease of non-hcv etiology. this includes, but is not limited to, acute hepatitis a infection, drug- or alcohol-related liver disease, autoimmune hepatitis, hemochromatosis, wilson's disease, alpha-1 antitrypsin deficiency, non-alcoholic steatohepatitis, primary biliary cirrhosis, or any other non-hcv liver disease considered clinically significant by the investigator
boolean
C0023895 (UMLS CUI [1])
C0015127 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0220847 (UMLS CUI [2,3])
C0019159 (UMLS CUI [3])
C0860207 (UMLS CUI [4])
C0023896 (UMLS CUI [5])
C0241910 (UMLS CUI [6])
C0018995 (UMLS CUI [7])
C0019202 (UMLS CUI [8])
C0221757 (UMLS CUI [9])
C3241937 (UMLS CUI [10])
C0008312 (UMLS CUI [11])
Therapy Illicit
Item
use of any disallowed therapies before the planned first dose of study drugs
boolean
C0087111 (UMLS CUI [1,1])
C0332266 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial